Therapeutic Asset Ratings
156 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Bbp-398
Cancer
Bristol-Myers Squibb
P1/2
D
(26)
Jcar017 (Lisocabtagene Maraleucel)
Plasma Cell Myeloma
Bristol-Myers Squibb
D
(26)
Trotabresib
Cancer
Bristol-Myers Squibb
P1
D
(21)
BMS-986463
Endometrial Serous Adenocarcinoma
Bristol-Myers Squibb
P1
NR
(0)
BMS-986504
Advanced Solid Tumors With Homozygous MTAP Deletion
Bristol-Myers Squibb
P1
NR
(0)
BMS-986369
T-Cell Non-Hodgkin Lymphoma
Bristol-Myers Squibb
P1/2
NR
(0)
Showing 151 to 156 of 156 assets
Previous
Page 7 of 7
Next